NCT06335914View on ClinicalTrials.gov

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

March 4, 2029

Study Completion Date

September 4, 2029

Conditions
Advanced Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Ga 68 PSMA-11 PET

Positron emission tomography (PET) imaging using Ga68 PSMA 11 radiotracer

DIAGNOSTIC_TEST

18F-DCFPyL PET

Positron emission tomography (PET) imaging using 18F-DCFPyL radiotracer.

DIAGNOSTIC_TEST

FDG PET

Positron emission tomography (PET) imaging using (18) F-fluorodeoxyglucose radiotracer.

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER